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Abstract 
 Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). It is a 
major global health problem. On the basis of clinical features, Hepatitis B can be correlated with Kamala. Kamala 
is caused due to aggravation of Pittadosha. Ayurvedic management of Kamala includes samshodhan and 
samshaman therapy which leads to break the samprapti of the disease and hence provides complete cure. In this 
case study  53 years old male patient having complaints of yellowish colored urine and reduced appetite along with 
generalized weakness, nausea and mild pain in right hypochondriac region was treated with herbomineral 
preparations (Phalatrikadi Kwath, Arogyavardhini Vati, Liv52 HB, Rohitakarishta etc.) described in classical texts 
of Ayurveda for 6 months. Assessment was done on the Subjective & Objective (Pathological) Parameters Before, 
after and during treatment. Significant improvement was observed in subjective and objective parameters after 
completion of treatment. From this study it can be concluded that Hepatitis B can be successfully managed with 
principles of Ayurveda. 
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Introduction 
 Hepatitis B is a potentially life-threatening liver 
infection caused by the hepatitis B virus (HBV). It is a 
major global health problem. It can cause chronic 
infection and puts people at high risk of death from 
cirrhosis and liver cancer. (1) Most cases of chronic 
hepatitis B among adults, however, occur in patients who 
never had a recognized episode of clinically apparent 
acute viral hepatitis. The degree of liver injury (grade) in 
patients with chronic hepatitis B is variable, ranging from 
none in inactive carriers to mild to moderate to severe. 
The spectrum of clinical features of chronic hepatitis B is 
broad, ranging from asymptomatic infection to 
debilitating disease or even end-stage, fatal hepatic 
failure.(2) 
There is a serious dearth of data regarding the true 
prevalence of HBV in India. HBsAg positivity has been 
reported to range between 2% and 8% in most studies. 
(3)  
 On the basis of clinical features, Hepatitis B can be 
correlated with Kamala Kamala is caused due to 
aggravation of Pittadosha. Ayurveda offers reference 
points for managing treatment decisions specific to each 
and every case and to project a vision or goal for a whole 
state of health, again unique to each and every case. 
Ayurvedic management of Kamala includes samshodhan 
and samshaman therapy which leads to break the 
samprapti of the disease and hence provides complete 
cure. This case can be helpful for the management of 
Hepatitis B by using herbomineral formulations given in 
Ayurveda.(4) 
 
Case report  
 A 53 years old male patient came to Kayachikitsa 
OPD (OPD No.1812180021) of Mahatma Gandhi 
Ayurveda College Hospital & Research Centre, Salod 
(H), Wardha with chief complaints of yellowish colored 
urine and reduced appetite. He also had associated 
complaints like generalized weakness, nausea and mild 
pain in right hypochondriac region.  
 
History of present illness 
 Patient was apparently alright before 3 months. 
Then he developed anorectal disease for which he was 
advised surgery and during investigations for the same, he 
was diagnosed as HBsAg Positive. After that he had 
developed symptoms like yellowish discoloration of urine 
with loss of appetite so he came to MGAC Hospital for 
the management. He gave history of nursing care of his 
father who had suffering from HBsAG since 5 years. 
 
Past history 
 There was no past history of Diabetes mellitus, 
Hypertension and Asthma. 
 
Family history 
 Father had history of HBsAG positive since 5 yrs. 
He had the history of blood transfusion prior to it. 
 
Clinical examination 
Ashtavidha pariksha was within normal limit 
except mutra and netra were yellowish in color. Patient 
had madhyam akruti. 
Dashavidha pariksha was within normal limit 
except aharshakti (abhyavarana, jaranshakti) and 
vyayamshakti were awar. 
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Vital Parameters-Vital parameters were within 
normal limit. 
 
Systemic Examination 
P/A – Abdomen was soft and mild Tenderness was 
present in right hypochondriac region. 
Investigation – Blood investigation revealed raise 
levels of SGOT, SGPT, Sr.bilirubin, etc. 
 
Diagnosis-From clinical features, physical examination 
and investigations patient was diagnosed having 
Hepatitis B (Kamala)  
Table 1: Treatment given 
 
 
Observation & Results 
Table 2: Observations of the study parameters 
 
Sr.No. Drug given Dose Duration /Time 
1 Arogyavardhini vati 250mg BD 14 days by interval of 7 days for 4 months/ after food 
2 Liv. 52 HB 125mg BD 6 months/ after food 
3 Punarnava mandoor 250mg BD 6 months/ after food 
4 Triphala churna 5gm 6 month / HS 
5 Pahala trikadi kwath 20ml BD 6 months/ after food 
6 Rohitakarishta 20ml BD 6 months/ after food 
SN   Parameter assessed 0 day On 30th day On 60th day On 90th day On 180th  day 
1. KFT Sr. Urea (mg %) 20.14 18 23 21 20 
Sr. Creatinine (mg %) 1.00 0.98 1.03 0.95 0.75 
Sr. Na (mmol/L) 137 140 143 145 140 
Sr. K (meq/L) 4.2 5.0 5.3 5.2 4.0 
2. 
  
LFT Sr.bilirubin (total) (mg %) 1.23 1.17 0.82 0.78 0.74 
Direct (mg %) 0.44 0.56 0.23 0.21 0.20 
Indirect (mg %) 0.79 0.61 0.59 0.56 0.52 
SGOT (IU/L) 69 85 56 52 20.11 
SGPT (IU/L) 32 37 36 37.2 26.14 
Alkaline phosphate(IU/L) 183 180 180 179 175 
 
3. 
USG  
abdomen 
Before 
Dilated CBD & fatty liver grade 2 
Liver- echo texture coarse 
After 
Mild dilated CBD & fatty liver grade 1. 
Liver- echo texture coarse 
4. Fibro 
scan 
Median stiffness 8 kPa, IQR- 0.8 
kPa, 
Median stiffness 6.0 kPa, IQR- 0.8 kPa, 
Discussion  
Hepatitis B is mainly caused due to Hepatitis B 
virus and can be correlated with kamala. Kamala is a 
disease which occurred due to vitiation of the pitta dosha 
dominantly. Samprapti ghatak includes Pitta dosha, 
Rakta, Mansa dushya, mahastrotas as a adhishthan. In 
Ayurveda various formulations are described for the 
management of kamala. In this case study formulations 
like Phalatrikadi kwath, Arogyavardhini vati, 
Rohitakarishta, Liv.52 HB, Triphala churna and 
Punarnava mandoor are used for the management of 
kamala. All these herbomineral formulations contain the 
drugs having tikta rasa, dipana, pachana, rechan, 
pittakaphashamaka, and yakruttotejaka and rasayana 
properties.  
 
Probable mode of action of medicines  
1. Phalatrikadi kwath is herbal formulation mentioned 
in the Siddhasara Nighantu for the management of 
Kamala. It contains eight herbs namely Haritaki 
(Terminalia chebula Retz.), Bibhitaka (Terminalia 
bellirica Roxb.), Amalaki (Emblica officinalis Gaertn.) 
Amruta (Tinospora cordifolia Thunb.), Vasa (Adhatoda 
vasica Nees), Katuka (Picrorhiza kurrooa Royle ex 
Benth.), Nimb (Azadirachta indica A. Juss) and 
Kairattikta (Swertia chirata Roxb . ex flem). All these 
drugs are having Pitta-Kapha Shamaka, Yakriduttejaka, 
Shothahara, Rechana and Dipana properties hence it is 
indicated in Kamala and pandu.()Being shothahar it may 
relives the shotha at the cellular level of liver, rechak 
properties acts as nitya virechak mainly indicated in 
kamala. Yakridduttejak and rasayan properties help to 
rejuvenate the liver cells.  
 Various research studies conducted proved its 
hepatoprotective, immune modulatory, anti-allergic, anti 
inflammatory and choleretic action. 
Hence Phalatrikadi kwath have hepato-cellular 
regeneration capacity, Cholegogue and cholertic activity, 
Membrane stabilizing effect, Antiviral and antioxidant 
effect, Molecular nutrient effect and property to correct 
metabolic activities due to enzymatic action.() 
 
2. Arogyawardhini Vati is rasaushadhi mentioned in 
Ayurveda Formulary () it is mainly indicated in treatment 
of jaundice, liver disorders, and various skin disorders. It 
consists of Haritaki (Terminalia chebula Retz.), Bibhitaka 
(Terminalia bellirica Roxb.), Amalaki (Emblica 
officinalis Gaertn.), Silajatu Suddha (Asphaltum), 
Guggulu Shuddha (Commiphora wightii), Eranda 
(Ricinus communis Linn. ), Katuka (Picrorrhiza kurroa 
Royle ex Benth.), leaf juice of Nimba (Azadirachta indica 
A. Juss) and minerals like  Shuddha Rasa (purified 
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mercury), Shuddha Gandhaka (purified sulfur), Lauha 
Bhasma (iron compound in ash form), Abhraka Bhasma 
(mica in ash form), and Tamra Bhasma (copper 
compounds in ash form). Vati has deepan, pachan, 
stotoshodhan, yakrita pliha shothhar, tridoshashamak 
properties. () Being deepan and pachan it acts on 
mandagni in the yakrit which leads to agnivardhan and 
formation of new cells in liver. Stotoshodhan relives the 
obstructed strotas occurred due to  kapha and pitta. Y akrit 
pliha shothahar property relives the shotha in yakrit.  
Research conducted on it proves its choleretic, anti-
inflammatory and antiviral action. Hence this drug is 
widely used in the hepatic disorders. () 
 
3. Triphala contains Haritaki, Vibhitaki and Amalaki. It 
has antioxidant properties. It is hepatoprotective in nature 
and protects liver from free radical damage. 
 
4. Punarnava mandoor According to Ayurvedic 
literature, most of the drugs in Punarnava 
Mandoor contents Triphala, Trikatu, Chitraka 
(Plumbago scandens L.), Vidanga (Embelia ribes 
Burm.f.) and Pippalimul (Piper longum L.) are deepan, 
pachan and vatanulomak properties. Hence it improves 
jaranshakti (digestive power) and ultimately absorption 
of nutrition and drug also. 
Trivrita (Operculina turpethum (L.) Silva Manso), 
Haritaki and Danti (Baliospermum montanum) acts as a 
nitya virechak. Other drug like Amalaki, 
Danti, Pippali, Punarnava, Kushtha(Aplotaxis lappa 
Decne.) and Daruharidra (Berberis aristata DC.) are 
immunomodulator and antioxidant properties.  
 
5. Rohitakarishta is a formulation for Yakrita and 
Plihavriddhi/Vikara mentioned in Bhaishjya Ratnavali. It 
has raktashodhak, pachak, deepan properties. Its Contents 
panchkol, dalchini(Cinnamomum verum J.Presl), tejpaan
(Cinnamomum tamala T.Nees), bruhat ela(Cardamom), 
and triphala. most of drugs are deepan and pachan 
properties.() Being Rakta shodhak removes impurities in 
rakta dhatu which involved in disease manifestration, 
deepan and pachan properties helps in correction of 
manda dhatuvagni at yakrit level. 
 
6. Liv52 HB  
LIV52 HB contains Mustaka (Cyperus rotundus Linn.) 
125 mg, Nagaramustaka (Cyperus scariosus R.Br.) 125 
mg. Mustaka being kashay, tikta, katu, rasatmak acts on 
jathar Agni and improves digestion. These drugs are 
having antiviral, anti microbial and hepatoprotective 
activity. It renormalizes liver functions which improves 
the appetite and liver enzymes.  
 
In this case study HBV Viral Load was not 
performed and where HBV DNA is unavailable, patients 
with hepatitis B can be assessed by liver ultrasound and 
routine laboratory tests.12 
In this case the improvement was assessed on the 
basis of reduction in symptoms and value of LFT with 
improvement in USG abdomen & fibro scan of liver after 
completion of treatment. All these parameters showed 
significant improvement hence, it can be stated that these 
drugs helps in improving the condition of patient 
suffering from hepatitis B.  
 
Conclusion  
 Formulations used in this case study helps in 
improving symptoms, causes reduction in values of liver 
function test with improvement in USG and fibroscan of 
patient. Hence it can be concluded that Hepatitis B can be 
successfully treated with formulations described in 
Ayurveda. They mainly contain drugs which act on liver 
and helps in improving the functioning of liver. 
This single case study hence to prove the efficacy of these 
drugs further study on large sample size is recommended. 
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